Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1984-06-21
1988-06-21
Marantz, Sidney
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
4351722, 43524027, 436544, 436548, 436813, 530387, 530389, 530808, 935104, 935110, C12N 500, C12N 1500, G01N 33532, G01N 33574
Patent
active
047525690
ABSTRACT:
Detection of sialylated Lewis.sup.x antigen in sera is employed as diagnostic of the presence of cancer. Conveniently, monoclonal antibodies are provided which are shown to be useful in the diagnosis of a neoplastic condition, with a wide variety of different tumors.
The hybridoma CSLEX1 was deposited at the A.T.C.C. on June 20, 1984 and given Accession No. HB8580.
REFERENCES:
T. M. Kloppel et al. Proc. Nat. Acad. Sci. (USA) 74 3011, 1977.
G. Kohler et al. Nature (London) 256 495, 1975.
K. Y. Pak et al. Hybridoma 3 1, 1984.
M. Blaszczyk et al. Int. Journ. Cancer 33, 313-318, 1984.
Fukushima Kiyoyasu
Hirota Masaki
Iguro Takashi
Terasaki Paul I.
Wakisaka Akemi
Marantz Sidney
Rowland Bertram I.
Saunders David A.
The Regents of the University of California
LandOfFree
Sialylated Lewis.sup.x epitope, antibodies and diagnosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sialylated Lewis.sup.x epitope, antibodies and diagnosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sialylated Lewis.sup.x epitope, antibodies and diagnosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-929691